Investor Relations

Operating through 4company-operated treatment centers, Greenbrook TMS Inc. is a leading provider of Transcranial Magnetic Stimulation (TMS), an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder (MDD), in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 160,000 TMS treatments to over 4,500 patients struggling with depression.

Recent Filings

For copies of our financial statements and other continuous disclosure filings, please see the Greenbrook TMS profile at SEDAR (System for Electronic Document Analysis and Retrieval) by clicking the link below.